MashupMD

Mashup Score: 7

Biocad starts Phase III trial for hemophilia B gene therapy | News | GxP News - 2 month(s) ago

Russian Ministry of Health has granted approval to Biocad to initiate a Phase III clinical trial for ANB-002, marking the introduction of the country’s. News GxP News.

Source: gxpnews.net

Categories: General Medicine News, Hem/Oncs

Tweet Tweets with this article
- ProfMakris
  
  New to me as I did not know there was a Russian hemophilia GT product. The Russian Authorities have given approval for a local phase 3 trial of gene therapy for #hemophilia B. It is AAV5 based and subjects can have anti-AAV5 antibodies. https://t.co/C0wB0QgNos